INCY · Company research
Incyte Genomics Inc (INCY): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| INCY,LEA | stock prices | quote comparison - Yahoo Finance UK | INCY,LEA | stock prices | quote comparison Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| Insider Sale: CMO & Head of Late-Stage Dev. of $INCY Sells 1,877 Shares - Quiver Quantitative | Insider Sale: CMO & Head of Late-Stage Dev. of $INCY Sells 1,877 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 14, 2026 | neutral | 0 | 0.6 |
| Incyte Corp. Stock Grades | INCY - Barron's | Incyte Corp. Stock Grades | INCY Barron's | View source ↗ | Barron's | Oct 13, 2026 | neutral | 0 | 0.6 |
| Incyte plans to publish third-quarter results at 7 a.m. Oct. 29, then hold a call at 8. - Stock Titan | Incyte plans to publish third-quarter results at 7 a.m. Oct. 29, then hold a call at 8. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| If You Invested $1000 In Incyte Stock 15 Years Ago, You Would Have This Much Today - Benzinga | If You Invested $1000 In Incyte Stock 15 Years Ago, You Would Have This Much Today Benzinga | View source ↗ | Benzinga | Oct 7, 2026 | neutral | 0 | 0.6 |
| Incyte Corporation (INCY) Stock Forecasts - Yahoo Finance | Incyte Corporation (INCY) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 7, 2026 | neutral | 0 | 0.6 |
| 463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. - Stock Titan | 463 shares are automatically withheld for taxes from Incyte (INCY) EVP Lee Heeson at $117.14 each. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Incyte (NasdaqGS:INCY) Stock Forecast & Analyst Predictions - Simply Wall Street | Incyte (NasdaqGS:INCY) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 5, 2026 | neutral | 0 | 0.6 |
| A legal chief with more than 25 years in pharma and biotech joins MiniMed. - Stock Titan | A legal chief with more than 25 years in pharma and biotech joins MiniMed. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data - Yahoo Finance | Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data Yahoo Finance | View source ↗ | Yahoo Finance | Sep 24, 2026 | neutral | 0 | 0.6 |
| Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data - Simply Wall Street | Incyte (INCY) Stock Could Be 33% Overvalued After Fresh EADV Data Simply Wall Street | View source ↗ | Simply Wall Street | Sep 24, 2026 | neutral | 0 | 0.6 |
| Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. - Stock Titan | Incyte (INCY) withheld shares from its strategy chief for taxes at a reported $126.93 per share. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Better Bet Than Amgen Stock: INCY, NBIX Deliver More - Trefis | Better Bet Than Amgen Stock: INCY, NBIX Deliver More Trefis | View source ↗ | Trefis | Aug 20, 2026 | neutral | 0 | 0.6 |
| Incyte (INCY) Stock Trades Reasonable On Earnings While Returns Look Strong - Yahoo Finance | Incyte (INCY) Stock Trades Reasonable On Earnings While Returns Look Strong Yahoo Finance | View source ↗ | Yahoo Finance | Aug 1, 2026 | neutral | 0 | 0.6 |
| Incyte (INCY) Stock Rallies As Profit Strength Fuels Diversification Debate - Simply Wall Street | Incyte (INCY) Stock Rallies As Profit Strength Fuels Diversification Debate Simply Wall Street | View source ↗ | Simply Wall Street | Jul 29, 2026 | neutral | 0 | 0.6 |
| Incyte stock jumps after Q2 beat and sharply higher 2026 sales outlook - Quiver Quantitative | Incyte stock jumps after Q2 beat and sharply higher 2026 sales outlook Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 28, 2026 | neutral | 0 | 0.6 |
| INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura - Zacks Investment Research | INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura Zacks Investment Research | View source ↗ | Zacks Investment Research | Jun 29, 2026 | neutral | 0 | 0.6 |
| Why Incyte (INCY) Stock Is Up Today - Yahoo Finance | Why Incyte (INCY) Stock Is Up Today Yahoo Finance | View source ↗ | Yahoo Finance | Jun 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.